Cargando…

A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies

Lung cancer is one of the most common cancers in the population and is characterized by non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological treatment. Due to the difficult placement of the tumor, one of the main methods of lung cancer treatment is radiotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak, Paulina, Bil-Lula, Iwona, Śliwińska-Mossoń, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342525/
https://www.ncbi.nlm.nih.gov/pubmed/37446385
http://dx.doi.org/10.3390/ijms241311206
_version_ 1785072519772897280
author Nowak, Paulina
Bil-Lula, Iwona
Śliwińska-Mossoń, Mariola
author_facet Nowak, Paulina
Bil-Lula, Iwona
Śliwińska-Mossoń, Mariola
author_sort Nowak, Paulina
collection PubMed
description Lung cancer is one of the most common cancers in the population and is characterized by non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological treatment. Due to the difficult placement of the tumor, one of the main methods of lung cancer treatment is radiotherapy, which damages the DNA of cancer cells, inducing their apoptosis. However, resistance to ionizing radiation may develop during radiotherapy cycles, leading to an increase in the number of DNA points of control that protect cells from apoptosis. Cancer stem cells are essential for radioresistance, and due to their ability to undergo epithelial–mesenchymal transition, they modify the phenotype, bypassing the genotoxic effect of radiotherapy. It is therefore necessary to search for new methods that could improve the cytotoxic effect of cells through new mechanisms of action. Chinese medicine, with several thousand years of tradition, offers a wide range of possibilities in the search for compounds that could be used in conventional medicine. This review introduces the potential candidates that may present a radiosensitizing effect on lung cancer cells, breaking their radioresistance. Additionally, it includes candidates taken from conventional medicine—drugs commonly available in pharmacies, which may also be significant candidates.
format Online
Article
Text
id pubmed-10342525
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103425252023-07-14 A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies Nowak, Paulina Bil-Lula, Iwona Śliwińska-Mossoń, Mariola Int J Mol Sci Review Lung cancer is one of the most common cancers in the population and is characterized by non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological treatment. Due to the difficult placement of the tumor, one of the main methods of lung cancer treatment is radiotherapy, which damages the DNA of cancer cells, inducing their apoptosis. However, resistance to ionizing radiation may develop during radiotherapy cycles, leading to an increase in the number of DNA points of control that protect cells from apoptosis. Cancer stem cells are essential for radioresistance, and due to their ability to undergo epithelial–mesenchymal transition, they modify the phenotype, bypassing the genotoxic effect of radiotherapy. It is therefore necessary to search for new methods that could improve the cytotoxic effect of cells through new mechanisms of action. Chinese medicine, with several thousand years of tradition, offers a wide range of possibilities in the search for compounds that could be used in conventional medicine. This review introduces the potential candidates that may present a radiosensitizing effect on lung cancer cells, breaking their radioresistance. Additionally, it includes candidates taken from conventional medicine—drugs commonly available in pharmacies, which may also be significant candidates. MDPI 2023-07-07 /pmc/articles/PMC10342525/ /pubmed/37446385 http://dx.doi.org/10.3390/ijms241311206 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nowak, Paulina
Bil-Lula, Iwona
Śliwińska-Mossoń, Mariola
A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
title A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
title_full A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
title_fullStr A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
title_full_unstemmed A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
title_short A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies
title_sort cross-talk about radioresistance in lung cancer—how to improve radiosensitivity according to chinese medicine and medicaments that commonly occur in pharmacies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342525/
https://www.ncbi.nlm.nih.gov/pubmed/37446385
http://dx.doi.org/10.3390/ijms241311206
work_keys_str_mv AT nowakpaulina acrosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies
AT billulaiwona acrosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies
AT sliwinskamossonmariola acrosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies
AT nowakpaulina crosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies
AT billulaiwona crosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies
AT sliwinskamossonmariola crosstalkaboutradioresistanceinlungcancerhowtoimproveradiosensitivityaccordingtochinesemedicineandmedicamentsthatcommonlyoccurinpharmacies